There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
We review recent advances in the biologic understanding and treatment of childhood
acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), identify therapeutically
challenging subgroups, and suggest future directions of research.